Tyrosine-kinase inhibitors in the treatment of muscle invasive bladder cancer and hormone refractory prostate cancer.
about
Tyrosine-kinase inhibitors in the treatment of muscle invasive bladder cancer and hormone refractory prostate cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Tyrosine-kinase inhibitors in ...... ne refractory prostate cancer.
@en
Tyrosine-kinase inhibitors in ...... ne refractory prostate cancer.
@nl
type
label
Tyrosine-kinase inhibitors in ...... ne refractory prostate cancer.
@en
Tyrosine-kinase inhibitors in ...... ne refractory prostate cancer.
@nl
prefLabel
Tyrosine-kinase inhibitors in ...... ne refractory prostate cancer.
@en
Tyrosine-kinase inhibitors in ...... ne refractory prostate cancer.
@nl
P2093
P1476
Tyrosine-kinase inhibitors in ...... ne refractory prostate cancer.
@en
P2093
Alain Ravaud
Grégoire Robert
Hervé Wallerand
Jean-Christophe Bernhard
P304
P577
2010-11-01T00:00:00Z